-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
-
Cosmetic Ingredient
- Water Treatment Chemical
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
Recently, the responsible comrades of the relevant departments of the National Medical Insurance Bureau were interviewed by reporters on issues such as the price of new coronavirus vaccines and the impact of purchasing vaccines on medical insurance funds that are generally concerned by the society
.
Q: What is the current domestic domestic vaccine price? A: Since the outbreak of the novel coronavirus pneumonia, the National Medical Insurance Administration has resolutely implemented the decisions and deployments of the Party Central Committee, with the aim of "people first, life first"
.
In February 2021, the state officially launched the free vaccination of residents with the new coronavirus vaccine.
The cost of vaccine procurement and vaccination is mainly borne by the medical insurance fund and finance.
At the same time, the National Medical Insurance Administration temporarily assumed the work of negotiating and negotiating the price of vaccine procurement with enterprises
.
In the early stage of free vaccination for residents, there were few new coronavirus vaccine manufacturers and insufficient production capacity, and the contradiction between supply and demand worldwide was very prominent
.
The National Medical Insurance Administration insisted on taking epidemic prevention and control as the top priority, and repeatedly communicated and coordinated with domestic vaccine manufacturers.
In the first round, the purchase price of inactivated vaccines was reduced to no more than 90 yuan per dose, which was generally lower than the international price provided by enterprises
.
Afterwards, we negotiated with the company many times, and pushed the company to continuously reduce the price, which has been reduced to about 40 yuan/dose and 20 yuan/dose
.
At the same time, cooperate with relevant departments to coordinate vaccine production enterprises with strong production capacity and large supply to provide 600 million doses of vaccines for free, so as to urge them to fulfill their social responsibilities
.
Recently, the National Medical Insurance Bureau has once again organized negotiations with enterprises, and the new negotiated price has been reduced to a lower level
.
Q: Will free vaccination for all affect the smooth operation of the medical insurance fund? A: At present, China has vaccinated 3.
2 billion doses of vaccines, and the cost of vaccines is more than 120 billion yuan, which is shared by the medical insurance fund and the government.
The cost of vaccine expenditures is within the affordable range of the medical insurance fund
.
It is precisely because the vaccination funds and other aspects are guaranteed in place that among the world's most populous countries, China's vaccination rate is the fastest and the coverage is the widest
.
In the next step, the National Medical Insurance Administration will continue to do a good job in ensuring the corresponding expenses in accordance with the needs of epidemic prevention and control, and serve the overall situation of epidemic prevention and control
.
.
Q: What is the current domestic domestic vaccine price? A: Since the outbreak of the novel coronavirus pneumonia, the National Medical Insurance Administration has resolutely implemented the decisions and deployments of the Party Central Committee, with the aim of "people first, life first"
.
In February 2021, the state officially launched the free vaccination of residents with the new coronavirus vaccine.
The cost of vaccine procurement and vaccination is mainly borne by the medical insurance fund and finance.
At the same time, the National Medical Insurance Administration temporarily assumed the work of negotiating and negotiating the price of vaccine procurement with enterprises
.
In the early stage of free vaccination for residents, there were few new coronavirus vaccine manufacturers and insufficient production capacity, and the contradiction between supply and demand worldwide was very prominent
.
The National Medical Insurance Administration insisted on taking epidemic prevention and control as the top priority, and repeatedly communicated and coordinated with domestic vaccine manufacturers.
In the first round, the purchase price of inactivated vaccines was reduced to no more than 90 yuan per dose, which was generally lower than the international price provided by enterprises
.
Afterwards, we negotiated with the company many times, and pushed the company to continuously reduce the price, which has been reduced to about 40 yuan/dose and 20 yuan/dose
.
At the same time, cooperate with relevant departments to coordinate vaccine production enterprises with strong production capacity and large supply to provide 600 million doses of vaccines for free, so as to urge them to fulfill their social responsibilities
.
Recently, the National Medical Insurance Bureau has once again organized negotiations with enterprises, and the new negotiated price has been reduced to a lower level
.
Q: Will free vaccination for all affect the smooth operation of the medical insurance fund? A: At present, China has vaccinated 3.
2 billion doses of vaccines, and the cost of vaccines is more than 120 billion yuan, which is shared by the medical insurance fund and the government.
The cost of vaccine expenditures is within the affordable range of the medical insurance fund
.
It is precisely because the vaccination funds and other aspects are guaranteed in place that among the world's most populous countries, China's vaccination rate is the fastest and the coverage is the widest
.
In the next step, the National Medical Insurance Administration will continue to do a good job in ensuring the corresponding expenses in accordance with the needs of epidemic prevention and control, and serve the overall situation of epidemic prevention and control
.